Contact Dermatitis

  1. What is Contact Dermatitis?
  2. Pathophysiology: Type IV Hypersensitivity vs Irritation
  3. Common Allergens in Allergic Contact Dermatitis
  4. Clinical Presentation and Pattern Recognition
  5. Patch Testing: Gold Standard for ACD Diagnosis
  6. Treatment of Contact Dermatitis
  7. Prevention and Avoidance Strategies
  8. Occupational Contact Dermatitis
  9. Special Situations: Latex Allergy and Photocontact Dermatitis
  10. Key Research Papers
  11. Connections
  12. Featured Videos

What is Contact Dermatitis?

Contact dermatitis is an inflammatory skin reaction caused by direct contact with a substance in the environment. It is one of the most common skin conditions seen in primary care and dermatology, accounting for millions of physician visits each year in the United States. The condition produces characteristic itching, redness, and sometimes blistering confined to areas of skin that touched the offending substance.

There are two fundamentally different mechanisms that produce contact dermatitis, and distinguishing between them matters enormously for treatment and avoidance:

Allergic Contact Dermatitis (ACD)

ACD is a type IV delayed hypersensitivity reaction — immune-mediated, T-cell driven, and completely unrelated to IgE antibodies. This means standard allergy blood tests (IgE panels, RAST testing) will be normal even in severely affected patients. There are two distinct phases: a sensitization phase on first exposure (no visible reaction; immune memory is quietly built over 10–21 days) and an elicitation phase on re-exposure, where symptoms develop after a characteristic 12–72 hour delay. This delay is the source of enormous diagnostic confusion — patients often blame whatever they touched that morning rather than a product used two days before.

Irritant Contact Dermatitis (ICD)

ICD is non-immune, direct toxic damage to the skin barrier — detergents, acids, alkalis, and physical friction strip the stratum corneum or denature skin proteins without involving T cells or immune memory. No prior sensitization is needed; it can occur on first exposure. ICD is by far the more common form, accounting for 70–80% of all contact dermatitis. It is dose-dependent: the more concentrated the irritant, the longer the exposure, or the more compromised the skin barrier, the worse the reaction. Hand eczema in dishwashers and health care workers who wash their hands dozens of times daily is the archetypal ICD presentation.

Less Common Forms

Phototoxic contact dermatitis occurs when a chemical in or on the skin is activated by ultraviolet light, producing what looks like an exaggerated sunburn in sun-exposed areas only. No immune sensitization is required — it can happen on first UV exposure. Photoallergic contact dermatitis is the immune-mediated counterpart: UV converts a chemical into a hapten that triggers T-cell sensitization, producing a delayed reaction in sun-exposed areas on re-exposure.

Prevalence

Allergic contact dermatitis affects approximately 15–20% of the population at some point in their lives. Nickel allergy — the single most common ACD allergen in most countries — has a lifetime prevalence of around 15% in women and 2% in men (reflecting the much higher prevalence of nickel-containing earrings and costume jewelry exposure in women). Occupational contact dermatitis is not a minor inconvenience: it accounts for roughly 90% of all occupational skin diseases and is a leading cause of work disability among health care workers, hairdressers, and construction workers.

Back to Table of Contents

Pathophysiology: Type IV Hypersensitivity vs Irritation

Allergic Contact Dermatitis: The Two-Phase Immune Cascade

Sensitization phase — On a person's very first contact with an allergen, nothing visible happens. The allergen is typically a small, lipophilic molecule called a hapten (nickel ions, urushiol from poison ivy, fragrance molecules) that penetrates the skin and binds to endogenous proteins, forming a complete antigen. Epidermal dendritic cells called Langerhans cells phagocytose this hapten-protein complex and migrate out of the skin to regional lymph nodes. There they present the antigen to naïve T cells, driving clonal expansion of allergen-specific T-effector and T-memory cells. This process takes 10–21 days. The patient has no symptoms whatsoever during sensitization, which is why a person can use a product for weeks or months before developing a reaction — the reaction on day 30 was initiated by the exposures on days 1–21.

Elicitation phase — On subsequent contact with the same hapten, Langerhans cells again present antigen, but now to abundant memory T cells. These activate rapidly, releasing pro-inflammatory cytokines including IFN-γ, TNF-α, and IL-17. Keratinocytes are damaged; fluid accumulates between them (spongiosis), and vesicles form. The hallmark 12–72 hour delay between exposure and visible reaction is the immunological fingerprint of Type IV hypersensitivity. It also explains why patients so often misidentify the cause: they notice the rash on Monday and blame Monday's lotion, but the reaction was actually triggered by Saturday's hair dye.

Irritant Contact Dermatitis: Direct Barrier Damage

In ICD, damage is proportional to dose, concentration, and duration of exposure — not to any immune response. Different irritants damage skin through different mechanisms: detergents and soaps dissolve the intercellular lipids of the stratum corneum that normally form a waterproof barrier; strong acids and alkalis denature structural proteins; physical friction mechanically removes corneocytes; repeated wetting and drying cycles strip away natural moisturizing factor and lipids. Inflammation follows from the release of cytokines by damaged keratinocytes — but without T-cell involvement. The clinical consequence is that ICD can occur on the very first exposure, and the reaction begins within minutes to hours rather than days.

Wet work — defined as having hands immersed in water or wearing occlusive gloves for more than two hours per day — is the leading risk factor for ICD. Health care workers, hairdressers, food handlers, and kitchen workers are at highest risk. Once the barrier is damaged by ICD, the skin becomes far more permeable to sensitizing chemicals, which is why workers with ICD frequently go on to develop ACD as well. The two conditions are not mutually exclusive; they often co-exist and amplify each other.

The Role of Skin Barrier Genetics

Loss-of-function mutations in the filaggrin gene (FLG) are now recognized as a major vulnerability factor for both ACD and atopic dermatitis. Filaggrin is a structural protein essential to the formation of the cornified envelope in the outermost skin layer. FLG mutations (carried by approximately 10% of Europeans) produce a structurally weaker barrier that allows greater allergen penetration, lower threshold for sensitization, and more persistent inflammation. Patients with FLG mutations who have atopic dermatitis are dramatically over-represented among those who develop ACD to multiple allergens — the so-called "atopic march" partially reflects this shared barrier defect.

Back to Table of Contents

Common Allergens in Allergic Contact Dermatitis

The North American Contact Dermatitis Group (NACDG) regularly publishes surveillance data on patch-test positivity rates across North America. The following represent the most clinically important allergens based on NACDG 2019–2020 data and decades of prior surveillance:

Nickel

The single most common contact allergen in most industrialized nations. Sources include costume jewelry (especially earring posts), belt buckles, watch clasps, phone cases, eyeglass frames, and body-piercing hardware. The EU enacted nickel regulations in 1994 restricting the amount of nickel that can be released from items in prolonged contact with skin; no equivalent regulation exists in the United States. Safer alternatives include titanium, niobium, surgical-grade stainless steel (316L), and gold above 18K. A cheap, over-the-counter dimethylglyoxime test kit can detect nickel leaching from any metal object in seconds.

Fragrance Mix and Balsam of Peru

Fragrance is the second most common cause of ACD and is present in more than one-third of all personal care products. The critical labeling loophole: a product labeled "fragrance" on the ingredient list may contain hundreds of individual chemical compounds, none of which must be individually disclosed. "Unscented" products frequently contain fragrance chemicals added to mask the smell of base ingredients — paradoxically making them potentially worse than fragrance-free alternatives. Balsam of Peru (Myroxylon pereirae) is a natural resin used as a fragrance ingredient that cross-reacts with cinnamon, vanilla, citrus peel, and many synthetic fragrance chemicals. A patient who reacts to Balsam of Peru may need to avoid a wide range of foods and products.

Formaldehyde and Formaldehyde-Releasing Preservatives

Formaldehyde itself is an allergen, but the greater clinical problem is the class of preservatives that slowly release formaldehyde in cosmetic and personal care products: quaternium-15, DMDM hydantoin, imidazolidinyl urea, and diazolidinyl urea. These are found in shampoos, conditioners, liquid soaps, lotions, and makeup. Occupational exposure occurs in the textile and garment industry (permanent-press fabrics are treated with formaldehyde resins), funeral homes, and construction materials. A patient sensitized to formaldehyde must read labels carefully for all of these releasing agents, not just "formaldehyde" itself.

Cobalt

Cobalt frequently co-sensitizes with nickel because the two metals are mined and processed together and are used in the same alloys. Independent sensitization to cobalt also occurs in cement workers (cobalt in Portland cement) and through cosmetics (cobalt-containing eye shadow pigments). The combination of nickel-cobalt co-sensitization is one reason construction workers are particularly vulnerable to ACD of the hands.

Rubber Chemicals

Natural rubber latex gloves contain chemical accelerators added during vulcanization — thiurams, carbamates, and mercaptobenzothiazoles — that are potent sensitizers. The resulting dermatitis appears on the hands in a glove distribution, but rubber chemicals also sensitize through elastic waistbands, condoms, shoe linings, and medical tubing. "Shoe dermatitis" affecting the dorsum of the foot is a classic presentation caused by rubber chemicals in shoe manufacturing. This is distinct from true latex allergy (Type I IgE-mediated), which causes immediate urticaria and can progress to anaphylaxis.

Para-Phenylenediamine (PPD)

PPD is the active ingredient in most permanent dark hair dyes (black, brown, auburn). It is also used in "black henna" temporary tattoos, where it is mixed into natural henna paste to produce a darker, longer-lasting color. Sensitization via black henna tattoos — especially popular at beach resorts and tourist destinations — has created an epidemic of PPD sensitization in children and young adults who then cannot safely use permanent hair dye ever after. Once sensitized to PPD, patients may cross-react with azo dyes in clothing, sunscreen chemicals (benzocaine, para-aminobenzoic acid), and rubber antioxidants.

Methylisothiazolinone (MI) and Methylchloroisothiazolinone (MCI)

MI and MCI are biocide preservatives that were increasingly used in "leave-on" cosmetics and wet wipes after 2008. The result was a significant epidemic of contact dermatitis — particularly in young children from wet wipes used in diaper care — that was eventually linked to MI sensitization. Regulatory restrictions on MI concentrations in leave-on products were introduced in Europe after 2013. MI remains in many rinse-off products, paints, and industrial coolants. Dermatologists examining children with persistent facial, neck, or buttock dermatitis should specifically inquire about wet wipe use.

Topical Antibiotics: Neomycin and Bacitracin

Neomycin is the most common antibiotic allergen, frequently sensitizing patients who apply combination antibiotic ointments (like Neosporin) repeatedly to wounds or chronic skin conditions. The irony is pronounced: a wound cream applied to facilitate healing becomes the cause of a persistent allergic eruption. Bacitracin deserves special mention because it can trigger not only delayed ACD but also immediate IgE-mediated reactions including anaphylaxis — a rare but life-threatening complication reported after bacitracin application to surgical wounds.

Poison Ivy, Poison Oak, and Poison Sumac (Urushiol)

Urushiol — the oily resin found in all parts of these plants — is the single most common cause of ACD in the United States. An estimated 50–70% of Americans will develop a reaction if exposed to sufficient amounts. The vesicular, linear, streaking eruption that develops 12–72 hours after brushing against the plant is classic. Crucially, burning the plants releases urushiol into smoke, causing respiratory tract involvement and eye inflammation in anyone downwind. Washing exposed skin with soap and water within 10–15 minutes of contact can reduce allergen load and reaction severity.

Back to Table of Contents

Clinical Presentation and Pattern Recognition

Contact dermatitis is as much a detective exercise as a medical one. The distribution of the rash on the body is often the most powerful diagnostic clue — far more informative than the appearance alone.

Morphology by Stage

In acute ACD, the skin shows intense erythema with vesicles (small blisters) that may weep serous fluid and crust. The borders are typically sharp, conforming precisely to the area of allergen contact. In subacute ACD, the vesicles resolve and scaling with crusting predominates. Chronic ACD from repeated low-level exposure produces lichenification (thickening and leathering of the skin from repeated scratching), excoriation marks, and fissuring of the skin surface. ICD tends to produce less vesiculation and more scaling and erythema with well-defined margins; patients with ICD more often describe burning or stinging rather than pruritus, which helps distinguish it from ACD where itching dominates.

Distribution as a Diagnostic Map

A Useful Trick: What the Ring Protects

When a patient has hand dermatitis, look carefully at the skin under rings and watchbands. If that skin is spared while the surrounding skin is affected, the ring is acting as a physical barrier against an irritant — pointing toward ICD from wet work or soaps. If the skin under the ring is the worst-affected area, the metal itself is the allergen — pointing toward ACD from nickel or gold in the ring. This simple bedside observation can redirect diagnostic thinking before a single test is ordered.

Back to Table of Contents

Patch Testing: Gold Standard for ACD Diagnosis

Patch testing is the definitive method for identifying the specific allergen(s) responsible for ACD. It is the only test that directly demonstrates Type IV hypersensitivity to a specific compound under controlled conditions. Blood tests, prick tests, and intradermal tests do not detect delayed T-cell reactions and have no role in diagnosing ACD.

How It Works

Standardized allergen preparations are applied to the patient's back in small aluminum chambers (Finn chambers) under occlusive tape. The most commonly used panel in the United States is the TRUE Test (Thin-layer Rapid Use Epicutaneous Test), a ready-to-use patch containing 35 standardized allergens. For more comprehensive evaluation, dermatologists and allergists use the NACDG Baseline Series — 65 or more allergens. The patches are left on the back for 48 hours under occlusion, then removed. Readings are performed at 48 hours and again at 72–96 or 120 hours. This second delayed reading is critical: cobalt, gold, and neomycin frequently show their peak reaction at 96–120 hours and will be missed if the patient is only seen once at 48 hours.

Interpreting Results

A positive reaction is defined as erythema with papules or vesicles at the allergen test site. Pustular or follicular reactions are not true positives. Crucially, a positive patch test alone is not sufficient — the result must be judged clinically relevant: the allergen must actually be present in the patient's environment, and the distribution and timeline of their dermatitis must be consistent with exposure to that allergen. Patch testing diagnoses sensitization; the clinician must determine whether that sensitization is responsible for the patient's specific complaint.

The "Angry Back" Pitfall

Excited skin syndrome, or "angry back," is a phenomenon in which a strongly positive reaction to one allergen nonspecifically hyperactivates all adjacent test sites, producing false-positive readings in nearby chambers. Recognizing this requires experience and often means retesting individual allergens in isolation on a separate occasion to confirm true sensitivity.

Practical Limitations

Patch testing cannot be performed if the patient has active widespread dermatitis on their back (there is no room to apply the test), is taking systemic corticosteroids above 10–15 mg prednisone equivalent per day (immune suppression will abolish the reaction), or has applied topical steroids to the test site in the preceding week. Photopatch testing extends the standard patch test by exposing half the allergens to UV light after 24 hours, detecting photoallergic reactions. The repeat open application test (ROAT) — applying a suspected product to the inner forearm twice daily for one week — provides real-world confirmation when patch test results are borderline or uncertain.

Back to Table of Contents

Treatment of Contact Dermatitis

The cornerstone of treatment is identifying and eliminating the causative substance. Without avoidance, all pharmacological treatments provide only temporary relief while the skin continues to be damaged. That said, acute reactions require active management, and chronic disease requires long-term skin barrier maintenance.

Acute Severe or Widespread ACD

Systemic corticosteroids are the most effective treatment for widespread or severe acute ACD. Prednisone is typically started at 40–60 mg/day. The single most important prescribing principle is the taper duration: the immune response in ACD is self-sustaining over 2–3 weeks, and courses stopped at 5–7 days almost inevitably produce a rebound flare as the steroid wears off before the T-cell response has exhausted itself. A 14–21 day taper is standard. Cool compresses and Burow's solution (dilute aluminum acetate) provide symptomatic relief for weeping, vesicular skin. Cool showers and calamine lotion reduce itch. Wet dressings can help dry weeping lesions overnight.

Topical Corticosteroids

Potency is matched to body site and severity. High-potency agents (clobetasol, halobetasol) are appropriate for localized acute ACD on the palms, soles, and thick skin of the trunk and limbs. Mid-potency agents (triamcinolone acetonide) are used for most body surfaces. Low-potency agents (1% hydrocortisone) are used for the face, eyelids, groin, and axillae, where the skin is thin and at greater risk of steroid-induced atrophy with prolonged use. Topical steroids applied under occlusion at night dramatically increase penetration and effectiveness for recalcitrant hand eczema.

Calcineurin Inhibitors

Tacrolimus 0.1% ointment (Protopic) and pimecrolimus 1% cream (Elidel) are T-cell inhibitors that suppress cutaneous inflammation without the atrophy risk of corticosteroids. Though FDA-approved only for atopic dermatitis, they are widely used off-label for ACD of the face, eyelids, and groin — areas where steroid atrophy is of greatest concern. They are a particularly valuable option for patients who need long-term maintenance therapy.

Antihistamines: A Frequently Misunderstood Role

Oral antihistamines (H1 blockers like cetirizine, loratadine) are often prescribed for ACD but have limited direct efficacy because the itch in ACD is driven by T-cell cytokines, not histamine. However, sedating antihistamines like hydroxyzine (Atarax) have a clear role in helping patients sleep through intense pruritus. Topical antihistamines should be avoided — diphenhydramine cream (Benadryl cream) is a well-documented sensitizer that causes ACD and is worse than useless in this setting.

Barrier Repair for ICD

For irritant contact dermatitis, emollient therapy is as important as any pharmacological treatment. Petrolatum (plain petroleum jelly) remains the gold standard barrier occlusive: it is non-sensitizing, cheap, and highly effective at reducing transepidermal water loss and allowing barrier repair. Ceramide-containing moisturizers help restore normal stratum corneum lipid composition. Cotton liner gloves worn under nitrile outer gloves provide both barrier protection and moisture management for those with wet-work exposure.

Advanced Therapies

Dupilumab (Dupixent, FDA-approved 2017 for atopic dermatitis) inhibits IL-4 and IL-13 signaling — cytokines shared between atopic dermatitis and ACD pathways. Clinical data support its use in chronic hand eczema, including cases with ACD co-morbidity. Narrowband UVB phototherapy is effective for chronic hand eczema and may benefit persistent ACD that does not respond to topical therapy alone. Alitretinoin (a retinoid approved in some countries for chronic hand eczema) is an option for cases refractory to topical therapy.

Back to Table of Contents

Prevention and Avoidance Strategies

For patients with established sensitization, avoidance of the offending allergen is the only definitive management. The following practical strategies address the most common sensitizers encountered in everyday life.

Fragrance Avoidance: Fragrance-Free vs Unscented

This distinction is critically important and widely misunderstood. "Fragrance-free" means the product contains no fragrance ingredients — it is what patients with fragrance ACD should look for. "Unscented" or "odorless" means the product has had additional chemicals added to mask its natural smell — these masking fragrance chemicals can themselves be allergens, making "unscented" products paradoxically worse for fragrance-sensitive patients. Patients should be explicitly taught to look for "fragrance-free" on the label, not "unscented," "naturally scented," or "hypoallergenic."

Nickel Avoidance

The dimethylglyoxime (DMG) spot test kit is available online for under $20 and allows patients to test any metal object for nickel leaching before purchasing. A pink color in under 30 seconds indicates significant nickel release. Safe jewelry metals include platinum, titanium, niobium, niobium-coated stainless steel, and gold above 18 carats (lower-karat gold alloys routinely contain nickel). A coat of clear barrier nail polish on the underside of a nickel-containing belt buckle or jean button can temporarily reduce skin contact while the patient seeks replacements.

Glove Strategy

Patients with rubber chemical or latex allergy should use vinyl or nitrile gloves, not latex or natural rubber gloves. When gloves are worn for extended periods, cotton liner gloves underneath prevent sweat accumulation that can macerate the skin and paradoxically worsen barrier damage. Occlusive gloves should never be worn for more than 15–20 minutes continuously without a break when possible. Powder-free gloves (for those who must use natural rubber) reduce aerosolized latex protein allergen significantly.

Hair Dye Alternatives for PPD-Sensitized Patients

Para-toluenediamine (PTD) is used in some permanent dyes as a lower-allergenicity alternative to PPD. However, cross-reactivity between PPD and PTD occurs in a minority of sensitized patients, so a patch test is advisable before first use. Semi-permanent dyes and henna are often recommended — but patients must understand that natural henna (pure Lawsonia inermis) is safe, while "black henna" (natural henna adulterated with PPD to produce darker color) is highly allergenic and is what originally sensitized many patients. The label or vendor must be scrutinized carefully.

Hand Care Programs for Wet-Work Exposures

For workers with unavoidable wet-work exposure, structured hand care programs have documented efficacy in reducing both ICD incidence and severity. The core components are: applying emollient immediately after handwashing and at the end of each work shift; using mild, pH-neutral soaps rather than antibacterial or degreasing agents; wearing protective gloves for tasks involving water, detergents, or cleaning chemicals; and performing alcohol-based hand rub (which is less damaging to the skin barrier than repeated soap-and-water washing) when hands are not visibly soiled.

Back to Table of Contents

Occupational Contact Dermatitis

Occupational contact dermatitis is the most prevalent occupational skin disease worldwide. It imposes major costs — both human (chronic, painful, career-ending disease) and economic (medical treatment, lost workdays, workers' compensation, retraining). Several occupational groups carry a dramatically elevated risk.

Hairdressers

Hairdressers face a convergence of every major contact dermatitis risk factor: prolonged wet work (shampooing, rinsing), PPD in permanent hair dyes, ammonium persulfate in bleaching agents (a potent sensitizer and also an IgE-mediated occupational asthma trigger), nickel in scissors and clips, and rubber chemicals in gloves. Hairdresser apprentices develop hand dermatitis at rates exceeding 50% in their first five years of training. Pre-employment skin screening and education about skin protection are now standard practice in many European countries but remain inconsistently implemented in the United States.

Health Care Workers

Repeated handwashing — a fundamental infection control requirement — is the primary driver of ICD in health care workers. The compromised skin barrier then becomes a portal for sensitization to rubber glove chemicals, disinfectants (glutaraldehyde, chlorhexidine), and antiseptics. Hand dermatitis affects 20–35% of nurses in some studies. Institutional interventions — alcohol-based hand rub substitution where possible, provision of fragrance-free moisturizers, and flexible glove policies — have documented effectiveness in reducing incidence.

Construction and Cement Workers

Portland cement contains water-soluble hexavalent chromium (chromate), a potent sensitizer responsible for the high prevalence of ACD among cement workers. The addition of ferrous sulfate to cement to reduce chromate to the less-soluble trivalent form — mandated in several European countries — dramatically reduced chromate ACD incidence. Cobalt in cement and epoxy resin systems used in construction adhesives and coatings add additional allergen burden. The NACDG baseline patch test series includes potassium dichromate specifically because of the public health importance of chromate sensitization.

Florists

Florists develop a distinctive constellation of ACD: chrysanthemum and Compositae family plants (sesquiterpene lactones), tulip bulbs (tulipalin A — producing the classic "tulip fingers": fissuring, hyperkeratosis, and erythema of the fingertips), garlic (diallyl disulfide — presenting as asymmetric fingertip dermatitis on the dominant-hand fingertips used to crush garlic), and plants in the Primula and Alstroemeria families. Most sensitizations are specific enough to require an extended patch test panel beyond the standard series.

Legal and Occupational Medicine Considerations

Occupational contact dermatitis is a legally compensable condition in most jurisdictions, but proving occupational causation requires documentation of the exposure history, onset timing, work distribution of the rash, improvement during time off, and worsening on return to work. Patch test results demonstrating sensitization to workplace allergens provide objective evidence. In severe or refractory cases, job modification or job change may be the only effective intervention. A multidisciplinary approach involving dermatology, occupational medicine, and the patient's employer produces the best outcomes in complex occupational ACD.

Back to Table of Contents

Special Situations: Latex Allergy and Photocontact Dermatitis

Latex Allergy: Type I vs Type IV — A Critical Distinction

Latex hypersensitivity encompasses two completely separate immunological mechanisms that are often conflated but have different clinical features, different diagnostic approaches, and different treatment implications.

Type I IgE-mediated latex allergy is caused by IgE antibodies against natural rubber latex proteins (particularly Hev b 1, Hev b 3, Hev b 5, Hev b 6, and Hev b 13). Reactions are immediate — urticaria, angioedema, rhinoconjunctivitis, bronchospasm, and anaphylaxis occurring within minutes of contact with latex products. High-risk groups include health care workers (repeated mucosal and skin exposure to latex gloves), patients with spina bifida (repeated urological and surgical procedures from infancy), and individuals with atopy or fruit allergies. The latex-fruit syndrome is cross-reactivity between latex proteins and proteins in banana, avocado, kiwi, chestnut, and occasionally apple, peach, and tomato — patients with latex allergy who develop reactions to these foods should be evaluated for latex IgE. Management requires a latex-free environment for surgical and medical procedures, synthetic glove use (nitrile, neoprene, vinyl), and epinephrine auto-injector prescription.

Type IV rubber chemical ACD is caused by T-cell sensitization to chemical accelerators (thiurams, carbamates, mercaptobenzothiazoles) added during glove vulcanization. This produces delayed hand dermatitis in a glove distribution without urticaria or systemic symptoms. Diagnosis is by patch test, not IgE testing. Treatment is switching to accelerator-free nitrile or vinyl gloves; the glove material itself (latex rubber) is not the problem.

Phototoxic Contact Dermatitis

Phototoxic reactions require no prior sensitization — any person exposed to sufficient concentrations of a photosensitizing chemical and sufficient UV radiation will react. The reaction looks like an exaggerated, sharply bordered sunburn in a distribution that precisely maps UV-exposed skin. The most clinically important photosensitizers include: furocoumarins in plants (parsley, celery, lime, bergamot — producing "lime disease" or "margarita dermatitis," the distinctive phototoxic reaction from lime juice on skin exposed to sunlight at outdoor events); certain sunscreen UV-absorbing chemicals (padimate-O, PABA); and drugs that concentrate in skin, most notably doxycycline and other tetracyclines, which cause significant photosensitivity even at therapeutic doses. Post-inflammatory hyperpigmentation after phototoxic reactions can be striking and persist for months.

Photoallergic Contact Dermatitis

Photoallergic reactions require prior sensitization, where UV light converts a stable chemical into a reactive hapten that then triggers a Type IV delayed immune response. The reaction occurs in sun-exposed areas after a 24–72 hour delay. The most common photoallergens are benzophenone-3 (oxybenzone) in chemical sunscreens and topical NSAIDs, particularly ketoprofen gel — marketed in Europe and widely used there, where photoallergic ACD to ketoprofen is a well-documented clinical entity. Diagnosis requires photopatch testing, where both standard patch testing and UV-irradiated allergen panels are applied simultaneously and compared. Management involves strict UV avoidance in addition to allergen avoidance.

Back to Table of Contents

Key Research Papers

The following peer-reviewed publications form the evidence base for the diagnosis, pathophysiology, and management of contact dermatitis.

  1. Menné T, Borgan Ø, Green A. Nickel allergy and hand dermatitis in a stratified sample of the Danish female population: an epidemiological study including a statistic appendix. Acta Derm Venereol. 1982;62(1):35–41. A foundational epidemiological study establishing the high prevalence of nickel allergy in women, quantifying the relationship between ear piercing and sensitization. Landmark work that supported subsequent EU nickel regulation. PMID 6172756
  2. Fonacier L, Bernstein DI, Pacheco K, et al. Contact dermatitis: a practice parameter — update 2015. J Allergy Clin Immunol Pract. 2015;3(3 Suppl):S1–39. Comprehensive clinical practice guidelines from the American College of Allergy, Asthma and Immunology covering diagnosis, patch testing methodology, interpretation, and management of ACD with systematic evidence review. PMID 25896188
  3. Zug KA, Warshaw EM, Fowler JF Jr, et al. Patch-test results of the North American Contact Dermatitis Group 2005-2006. Dermatitis. 2009;20(3):149–60. NACDG surveillance data on allergen positivity rates across North American patch test centers, establishing the epidemiological foundation for standard baseline allergen panels and revealing fragrance and preservative trends. PMID 19282697
  4. Diepgen TL, Haustein UF, Fartasch M. Occupational skin diseases in Germany — prevention and epidemiology. Contact Dermatitis. 2012;67(6):333–9. Analysis of occupational contact dermatitis incidence in Germany with detailed breakdown by industry sector. Quantifies the economic and epidemiological burden and evaluates prevention program effectiveness across high-risk occupational groups. PMID 22118684
  5. Nosbaum A, Vocanson M, Rozieres A, Hennino A, Nicolas JF. Allergic and irritant contact dermatitis. Eur J Dermatol. 2009;19(4):325–32. Mechanistic review comparing the cellular and molecular pathways of ACD and ICD, with particular focus on the role of Langerhans cells, regulatory T cells, and cytokine networks in distinguishing the two conditions. PMID 19423430
  6. Schalock PC, Dunnick CA, Nedorost S, et al. American Contact Dermatitis Society Core Allergen Series: 2020 update. Dermatitis. 2020;31(4):279–82. Updated recommendations for the minimum patch test allergen series from the American Contact Dermatitis Society, establishing consensus on which allergens should be included in all standard evaluations for ACD. PMID 32604297
  7. Bonamonte D, Foti C, Vestita M, Ranieri LD, Angelini G. Nummular eczema and contact allergy: a retrospective study. Dermatitis. 2012;23(4):153–7. Investigation of contact allergy co-morbidity in patients with nummular and foot eczema, with specific analysis of shoe material sensitization patterns including rubber chemicals and chromate in leather, clarifying the diagnostic approach to foot dermatitis. PMID 22805342
  8. Warshaw EM, Maibach HI, Taylor JS, et al. North American Contact Dermatitis Group patch test results: 2011-2012. Dermatitis. 2015;26(1):49–59. NACDG surveillance data from 4,231 patients identifying methylisothiazolinone as the single allergen with the greatest increase in positivity rate, documenting the MI epidemic that prompted subsequent regulatory action in Europe. PMID 25581800
  9. Warshaw EM, Zug KA, Belsito DV, et al. Positive patch-test reactions to essential oils in consecutive patients: results from North American Contact Dermatitis Group, 2013-2014. Dermatitis. 2017;28(4):246–52. NACDG 2013–2014 data documenting rising rates of essential oil sensitization alongside traditional fragrance allergens, relevant to the increasing use of "natural" fragrance products presumed to be safer. PMID 28443816
  10. Thyssen JP, Johansen JD, Menné T. Contact allergy epidemics and their controls. Contact Dermatitis. 2007;56(4):185–95. Historical analysis of major contact allergen epidemics including nickel, chromate, and paraphenylenediamine, examining how regulatory interventions (EU nickel directive, ferrous sulfate addition to cement) successfully reduced sensitization rates. Essential reading for understanding prevention policy. PMID 17661976
  11. Usatine RP, Riojas M. Diagnosis and management of contact dermatitis. Am Fam Physician. 2010;82(3):249–55. Practical primary care-focused review of contact dermatitis diagnosis and management, emphasizing pattern recognition, the clinical distinction between ACD and ICD, and evidence-based treatment choices for generalist physicians. PMID 20685005
  12. Fonacier L, Bernstein DI, Pacheco K, et al. Patch testing: a review of indications, methods, and interpretations. J Allergy Clin Immunol Pract. 2020;8(4):1198–1207. Position statement providing updated guidance on patient selection for patch testing, panel selection, reading schedules, interpretation of late reactions, and the clinical relevance determination process. Reference standard for patch testing practice in the United States. PMID 32059898

Back to Table of Contents

Connections

Back to Table of Contents